BioNTech SE

BioNTech CFO Dives into Insider Buying, Doubles Stake as Executives Bet Big on mRNA Growth Flare‑Up

Insider buying spree at BioNTech shows executives’ confidence in the company’s oncology and mRNA pipeline, hinting at a potential rebound for investors.

BioNTech SE
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

13/05/2026, 22:28

4 minutes to read

COO Poetting’s €5.5 million BioNTech sell‑off sparks “liquidity, not loss” debate as shares rebound on pipeline buzz.

BioNTech insider sale: COO Sierk Poetting sells 50k shares. Is this a sign of declining confidence? Learn what the move means for investors and the company’s growth prospects.

BioNTech SE
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

23/04/2026, 22:18

2 minutes to read